These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33376033)

  • 1. Blood urea nitrogen-to-serum albumin ratio and A-DROP are useful in assessing the severity of Pneumocystis pneumonia in patients without human immunodeficiency virus infection.
    Akahane J; Ushiki A; Kosaka M; Ikuyama Y; Matsuo A; Hachiya T; Yoshiike F; Koyama S; Hanaoka M
    J Infect Chemother; 2021 May; 27(5):707-714. PubMed ID: 33376033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research on risk factors of short-term outcome in AIDS patients with pneumocystis pneumonia].
    Li AX; Huang CY; Zhang HW; Zhang T; Wu H; Wang W
    Zhonghua Yi Xue Za Zhi; 2017 Mar; 97(11):833-837. PubMed ID: 28355738
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood urea nitrogen to serum albumin ratio independently predicts 30-day mortality and severity in patients with Escherichia coli bacteraemia.
    Zou XL; Feng DY; Wu WB; Yang HL; Zhang TT
    Med Clin (Barc); 2021 Sep; 157(5):219-225. PubMed ID: 33059940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection.
    Kim SJ; Lee J; Cho YJ; Park YS; Lee CH; Yoon HI; Lee SM; Yim JJ; Lee JH; Yoo CG; Lee CT; Kim YW; Han SK; Kim HB; Park JS
    J Infect; 2014 Jul; 69(1):88-95. PubMed ID: 24607411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of blood urea nitrogen-to-serum albumin ratio for mortality of pneumonia in patients receiving glucocorticoids: Secondary analysis based on a retrospective cohort study.
    Xia B; Song B; Zhang J; Zhu T; Hu H
    J Infect Chemother; 2022 Jun; 28(6):767-773. PubMed ID: 35272941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood urea nitrogen to serum albumin ratio: a good predictor of in-hospital and 90-day all-cause mortality in patients with acute exacerbations of chronic obstructive pulmonary disease.
    Zeng Z; Ke X; Gong S; Huang X; Liu Q; Huang X; Cheng J; Li Y; Wei L
    BMC Pulm Med; 2022 Dec; 22(1):476. PubMed ID: 36522751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective cohort study.
    Miyake K; Senoo S; Shiiba R; Itano J; Kimura G; Kawahara T; Tamura T; Kudo K; Kawamura T; Nakahara Y; Higo H; Himeji D; Takigawa N; Miyahara N;
    PLoS One; 2024; 19(2):e0292507. PubMed ID: 38330061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of tools for predicting the risk of death and ICU admission of non-HIV-infected patients with
    Jin F; Liang H; Chen WC; Xie J; Wang HL
    Front Public Health; 2022; 10():972311. PubMed ID: 36424963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Admission C-Reactive Protein-to-Albumin Ratio Predicts the 180-Day Mortality of AIDS-Related Pneumocystis Pneumonia.
    Wang H; Chang Y; Cui ZZ; Liu ZJ; Ma SF
    AIDS Res Hum Retroviruses; 2020 Sep; 36(9):753-761. PubMed ID: 32580561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection.
    Asai N; Motojima S; Ohkuni Y; Matsunuma R; Nakashima K; Iwasaki T; Nakashita T; Otsuka Y; Kaneko N
    J Infect Chemother; 2012 Dec; 18(6):898-905. PubMed ID: 22692598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the Epidemiology and Outcomes of Pneumocystis Pneumonia among Human Immunodeficiency Virus (HIV) Hospitalizations.
    Elango K; Mudgal M; Murthi S; Yella PR; Nagrecha S; Srinivasan V; Sekar V; Koshy M; Ramalingam S; Gunasekaran K
    Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Manifestations and Prognostic Factors of Pneumocystis jirovecii Pneumonia without HIV.
    Asai N; Motojima S; Ohkuni Y; Matsunuma R; Iwasaki T; Nakashima K; Sogawa K; Nakashita T; Kaneko N
    Chemotherapy; 2017; 62(6):343-349. PubMed ID: 28719897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus.
    Zar HJ; Dechaboon A; Hanslo D; Apolles P; Magnus KG; Hussey G
    Pediatr Infect Dis J; 2000 Jul; 19(7):603-7. PubMed ID: 10917216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase to albumin ratio as a prognostic factor in lower respiratory tract infection patients.
    Lee BK; Ryu S; Oh SK; Ahn HJ; Jeon SY; Jeong WJ; Cho YC; Park JS; You YH; Kang CS
    Am J Emerg Med; 2022 Feb; 52():54-58. PubMed ID: 34864628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for IRIS in HIV-associated Pneumocystis-pneumonia following ART initiation.
    Kann G; Wetzstein N; Bielke H; Schuettfort G; Haberl AE; Wolf T; Kuepper-Tetzel CP; Wieters I; Kessel J; de Leuw P; Bickel M; Khaykin P; Stephan C
    J Infect; 2021 Sep; 83(3):347-353. PubMed ID: 34242683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes.
    Matsumura Y; Shindo Y; Iinuma Y; Yamamoto M; Shirano M; Matsushima A; Nagao M; Ito Y; Takakura S; Hasegawa Y; Ichiyama S
    BMC Infect Dis; 2011 Mar; 11():76. PubMed ID: 21439061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-HIV-infected patients with Pneumocystis pneumonia in the intensive care unit: A bicentric, retrospective study focused on predictive factors of in-hospital mortality.
    Wang Y; Huang X; Sun T; Fan G; Zhan Q; Weng L
    Clin Respir J; 2022 Feb; 16(2):152-161. PubMed ID: 35001555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors of Mortality From
    Wang Y; Zhou X; Saimi M; Huang X; Sun T; Fan G; Zhan Q
    Front Public Health; 2021; 9():680108. PubMed ID: 34222179
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis.
    Liu Y; Su L; Jiang SJ; Qu H
    Oncotarget; 2017 Aug; 8(35):59729-59739. PubMed ID: 28938676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.